Dr. Hordinsky discusses how clascoterone 5% topical solution may reshape male AGA management and expand treatment confidence.

If you’re reading this because you’re losing your hair, you’re not alone — hair loss is a common issue affecting more than half of men by the time they’re in their forties. The most common type of ...

New 2025 study results show Clascoterone, originally approved for acne, could be the first new effective topical for male ...

Cosmo Pharmaceuticals has revealed topline results from two phase 3 trials which indicate that its topical cream clascoterone ...

If you’ve started to notice the early signs of hair loss, it’s easy to wonder what’s causing you to shed hair. Telogen effluvium and androgenetic alopecia are two common forms of hair loss. One causes ...

Potential side effects of using minoxidil should be considered before taking this medication. Using the oral form of the ...

Cosmo Pharmaceuticals says its Phase 3 trials of topical clascoterone for male-pattern hair loss showed statistically ...

Please provide your email address to receive an email when new articles are posted on . 81% of surveyed prescribers were in support of using oral minoxidil to treat androgenetic alopecia. Prescribers ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. ET-02 is a topical treatment that targets hair follicle ...

Clascoterone will be the first ever drug in 30 years to treat male pattern baldness by boosting hair growth by 500% ...

Washington D.C., leads the country, filling hair-loss prescriptions at more than five times the national average, followed by ...